Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
From the pages of AllergyWatch.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: May 12, 2026
Discordance between International Classification of Diseases, 10th Revision asthma severity codes and treatment-based measures of disease severity.
Journal: The journal of allergy and clinical immunology. In practice
Published: April 15, 2026
Discordance Between ICD-10 Asthma Severity Codes and Treatment-Based Measures of Disease Severity.
Journal: The journal of allergy and clinical immunology. In practice
Published: April 15, 2026
Penicillin allergy labels increase risks of MRSA colonization, surgical site infections, and mortality.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: March 29, 2026
Reply to "Biologic treatment for asthma during pregnancy is not associated with reduced adverse pregnancy outcomes: a replication study".
Journal: The journal of allergy and clinical immunology. In practice
Published: March 20, 2026
From the pages of AllergyWatch.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: March 09, 2026
From the pages of AllergyWatch.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: January 14, 2026
From the pages of AllergyWatch.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: January 14, 2026
Glucagon-Like Peptide-1 Receptor Agonists in Asthma and Obesity-Associated Asthma: A Systematic Review of Clinical Outcomes and Translational Mechanisms.
Journal: The journal of allergy and clinical immunology. In practice
Published: December 29, 2025
Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real-World Study on Effectiveness and Safety in Dupilumab Nonresponders.
Journal: Pediatrics
Published: November 30, 2025
Last Updated: 09/26/2026